Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONStandard

ZIRABEV

BEVACIZUMAB-BVZR

Standard Dose
100MG/4ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview ZIRABEV is listed in Drugs@FDA under application 761099 (BLA).

Review priority: STANDARD Marketing status: Prescription Active ingredient BEVACIZUMAB-BVZR Form and strength INJECTABLE;INJECTION - 100MG/4ML Sponsor PFIZER INC Submission history Latest submission status date: 2024-08-28 00:00:00.

Structured Monograph

Clinical summary

Approval overview ZIRABEV is listed in Drugs@FDA under application 761099 (BLA). Review priority: STANDARD Marketing status: Prescription Active ingredient BEVACIZUMAB-BVZR Form and strength INJECTABLE;INJECTION - 100MG/4ML Sponsor PFIZER INC Submission history Latest submission status date: 2024-08-28 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.